Company Filing History:
Years Active: 2013
Title: Philippe G Prokocimer: Innovator in Antibiotic Therapy
Introduction
Philippe G Prokocimer is a notable inventor based in Cardiff by the Sea, California. He has made significant contributions to the field of antibiotic therapy, particularly through his innovative patent.
Latest Patents
Prokocimer holds a patent for a therapeutic combination of daptomycin and a protein synthesis inhibitor antibiotic. This combination is designed to provide an antibacterially effective amount of daptomycin, along with an effective amount of a protein synthesis inhibitor antibiotic. The goal is to prevent the development of daptomycin non-susceptibility in bacteria. Related combination therapies and methods are also included in his patent.
Career Highlights
Philippe G Prokocimer is associated with Trius Therapeutics, Inc., where he has been instrumental in advancing antibiotic therapies. His work focuses on developing effective treatments that address bacterial resistance, a growing concern in modern medicine.
Collaborations
Prokocimer has collaborated with notable colleagues, including Kenneth Bartizal and Jeffrey Brian Locke. Their combined expertise has contributed to the success of their projects and innovations in the field.
Conclusion
Philippe G Prokocimer's work in antibiotic therapy exemplifies the importance of innovation in combating bacterial resistance. His contributions continue to influence the development of effective treatments in the medical field.